Nocion Therapeutics

Nocion Therapeutics is a clinical-stage biopharmaceutical company discovering and developing a novel class of biologically selective charged sodium channel (NaV) blockers designed to selectively silence overactive sensory neurons to relieve chronic cough, pain, itch, and inflammation. Its lead candidate, inhaled taplucainium, is a first-in-class therapy in a Phase 2b (ASPIRE) trial for refractory and unexplained chronic cough, with topline results expected in 2026. Founded on foundational intellectual property licensed from Harvard University and Boston Children's Hospital and backed by Canaan Partners, F-Prime Capital, and other life-sciences investors, Nocion is a therapeutics R&D company with no public developer API surface.

Nocion Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Biotech, Therapeutics, and Life Sciences.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiopharmaceuticalBiotechTherapeuticsLife SciencesChronic CoughDrug DevelopmentHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/nocion: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Nocion Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: nocion
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/nocion.png
name: Nocion Therapeutics
description: Nocion Therapeutics is a clinical-stage biopharmaceutical company discovering and developing a novel class of
  biologically selective charged sodium channel (NaV) blockers designed to selectively silence overactive sensory neurons
  to relieve chronic cough, pain, itch, and inflammation. Its lead candidate, inhaled taplucainium, is a first-in-class therapy
  in a Phase 2b (ASPIRE) trial for refractory and unexplained chronic cough, with topline results expected in 2026. Founded
  on foundational intellectual property licensed from Harvard University and Boston Children's Hospital and backed by Canaan
  Partners, F-Prime Capital, and other life-sciences investors, Nocion is a therapeutics R&D company with no public developer
  API surface.
url: https://raw.githubusercontent.com/api-evangelist/nocion/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biopharmaceutical
- Biotech
- Therapeutics
- Life Sciences
- Chronic Cough
- Drug Development
- Healthcare
apis: []
common:
- type: DomainSecurity
  url: security/nocion-domain-security.yml
- type: Website
  url: https://nociontx.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1